# Evaluation of the Autonomic Nervous System During First-dosing With 0.5mg of Fingolimod (Gilenya) in Patients With Relapsing-remitting MS

> **NCT02048072** · PHASE4 · COMPLETED · sponsor: **Jochen Vehoff** · enrollment: 33 (actual)

## Conditions studied

- Multiple Sclerosis
- Autonomic Nervous System Dysfunction

## Interventions

- **DRUG:** Gilenya

## Key facts

- **NCT ID:** NCT02048072
- **Lead sponsor:** Jochen Vehoff
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2016-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02048072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02048072, "Evaluation of the Autonomic Nervous System During First-dosing With 0.5mg of Fingolimod (Gilenya) in Patients With Relapsing-remitting MS". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT02048072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*